
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of IMUGENE LTD by Imugene, Ltd. (OTCPK:IUGNF) through any online brokerage.
There are no as such competitors for IMUGENE LTD by Imugene, Ltd..
There is no analysis for IMUGENE LTD by Imugene, Ltd. to provide a consensus price target.
The stock price for IMUGENE LTD by Imugene, Ltd. (OTCPK: IUGNF) is $0.0579 last updated October 16, 2026 at 2:43 PM EDT.
There are no upcoming dividends for IMUGENE LTD by Imugene, Ltd..
IMUGENE LTD by Imugene, Ltd. does not have any upcoming earnings scheduled.
There is no upcoming split for IMUGENE LTD by Imugene, Ltd..
IMUGENE LTD by Imugene, Ltd. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Imugene Ltd is an Australian-headquartered clinical stage cell therapy company developing an Allogeneic CAR T for blood cancers. Its lead asset is an off-the-shelf (allogeneic) cell therapy CAR T drug azer-cel (azercabtagene zapreleucel) which...